DNPUF:OTCMKTS
Sumitomo Pharma Co Ltd
9,79 $
0,00%
(0,00) 1D
16 қыр., 15:47:50 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNPUF...
Mkt. cap
714,91 млрд
Avg. vol.
50,00
Volume
0,00
52-wk high
19,20 $
52-wk low
8,40 $
Beta
0,38
Shares outstanding
449,20 млн
No. of employees
3 мың
Mkt. cap
714,91 млрд
Avg. vol.
50,00
Volume
0,00
52-wk high
19,20 $
52-wk low
8,40 $
Beta
0,38
Shares outstanding
449,20 млн
No. of employees
3 мың
News stories
From web sources and news partners
TradingView
·
51 минут бұрын
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
Yahoo Finance
·
1 сағат бұрын
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Quiver Quantitative
·
1 сағат бұрын
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
Seeking Alpha
·
40 минут бұрын
Depreciation Subtleties: S&P Earnings Are Vastly Overstated (NYSEARCA:SPY)
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees3,12 мың
Founded1897 ж. 14 мам.
HeadquartersОсака, Osaka, Жапония
SectorPharmaceutical industry
Websitesumitomo-pharma.co.jp